DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CO-ZIDOCAPT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CO-ZIDOCAPT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C16H23ClN4O7S3
Molecular Weight:
515.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TTP-607
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms
Serine/threonine-protein kinase Aurora inhibitor
TTP-607
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
J147
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
J147
×
Maximum Phase:
1
First Approval:
None
UNII:
Z41H3C5BT9
Molecule Type:
Small molecule
Molecular Formula:
C18H17F3N2O2
Molecular Weight:
350.34
AlogP:
4.24
PSA:
41.9
HBD:
0.0
HBA:
#RotB:
4.0
Source:
DUBERMATINIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Neoplasms
Unknown
DUBERMATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
14D65TV20J
Molecule Type:
Small molecule
Molecular Formula:
C24H30ClN7O2S
Molecular Weight:
516.07
AlogP:
3.61
PSA:
93.7
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BI 639667
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 639667
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H18FN5O3S
Molecular Weight:
451.48
AlogP:
2.78
PSA:
106.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IOMAZENIL
1
Small molecule
Investigational
Unknown
Unknown
Cognitive Dysfunction; Mental Disorders; Schizophrenia
Unknown
IOMAZENIL
×
Maximum Phase:
1
First Approval:
None
UNII:
7DVX185FLQ
Molecule Type:
Small molecule
Molecular Formula:
C15H14IN3O3
Molecular Weight:
411.2
AlogP:
2.24
PSA:
64.43
HBD:
0.0
HBA:
#RotB:
2.0
Source:
RO-3201195
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
RO-3201195
×
Maximum Phase:
1
First Approval:
None
UNII:
TE3ESF890C
Molecule Type:
Small molecule
Molecular Formula:
C19H18FN3O4
Molecular Weight:
371.37
AlogP:
1.56
PSA:
110.6
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TALETRECTINIB ADIPATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
TALETRECTINIB ADIPATE
×
Maximum Phase:
1
First Approval:
None
UNII:
6KLL51GNBG
Molecule Type:
Small molecule
Molecular Formula:
C29H34FN5O5
Molecular Weight:
551.62
AlogP:
4.43
PSA:
77.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
HSD-016
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HSD-016
×
Maximum Phase:
1
First Approval:
None
UNII:
C4I13768E1
Molecule Type:
Small molecule
Molecular Formula:
C21H21F7N2O3S
Molecular Weight:
514.46
AlogP:
4.51
PSA:
60.85
HBD:
1.0
HBA:
#RotB:
4.0
Source:
PKI-166
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PKI-166
×
Maximum Phase:
1
First Approval:
None
UNII:
9RIE5HW38P
Molecule Type:
Small molecule
Molecular Formula:
C20H18N4O
Molecular Weight:
330.39
AlogP:
4.5
PSA:
73.83
HBD:
3.0
HBA:
#RotB:
4.0
Source:
MK3207
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
MK3207
×
Maximum Phase:
1
First Approval:
None
UNII:
5C44M1QYCC
Molecule Type:
Small molecule
Molecular Formula:
C31H29F2N5O3
Molecular Weight:
557.6
AlogP:
3.77
PSA:
103.43
HBD:
3.0
HBA:
#RotB:
4.0
Source:
VS-5584
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Mesothelioma
PI3-kinase class I inhibitor
VS-5584
×
Maximum Phase:
1
First Approval:
None
UNII:
W71J4X250V
Molecule Type:
Small molecule
Molecular Formula:
C21H14F2N6O2
Molecular Weight:
420.38
AlogP:
3.11
PSA:
90.62
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FRUCTOSE
1
Small molecule
Investigational
Unknown
Unknown
Hypoglycemia; Melanoma; Non-alcoholic Fatty Liver Disease; Obesity
Unknown
FRUCTOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
6YSS42VSEV
Molecule Type:
Small molecule
Molecular Formula:
C6H12O6
Molecular Weight:
180.16
AlogP:
-3.22
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
2.0
Source:
AST-487
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase receptor FLT3 inhibitor
AST-487
×
Maximum Phase:
1
First Approval:
None
UNII:
W34UO2M4T6
Molecule Type:
Small molecule
Molecular Formula:
C26H30F3N7O2
Molecular Weight:
529.57
AlogP:
5.11
PSA:
94.65
HBD:
3.0
HBA:
#RotB:
8.0
Source:
TRICETAMIDE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase JAK1 inhibitor
TRICETAMIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
V6X0RFU7AF
Molecule Type:
Small molecule
Molecular Formula:
C16H24N2O5
Molecular Weight:
324.38
AlogP:
1.31
PSA:
77.1
HBD:
1.0
HBA:
#RotB:
8.0
Source:
RG7185
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
RG7185
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CS-8080
1
Small molecule
Investigational
Unknown
Unknown
Unknown
LXR-alpha agonist
CS-8080
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TINOSTAMUSTINE
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Gliosarcoma; Melanoma; Multiple Myeloma
Unknown
TINOSTAMUSTINE
×
Maximum Phase:
1
First Approval:
None
UNII:
29DKI2H2NY
Molecule Type:
Small molecule
Molecular Formula:
C19H28Cl2N4O2
Molecular Weight:
415.37
AlogP:
3.86
PSA:
70.39
HBD:
2.0
HBA:
#RotB:
12.0
Source:
ORDOPIDINE
1
Small molecule
Investigational
Unknown
Unknown
Parkinson Disease
Dopamine D2 receptor modulator
ORDOPIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0P43SIA7J6
Molecule Type:
Small molecule
Molecular Formula:
C14H20FNO2S
Molecular Weight:
285.38
AlogP:
2.43
PSA:
37.38
HBD:
0.0
HBA:
#RotB:
3.0
Source:
ONAMETOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes
Unknown
ONAMETOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
N8VKI8FPW0
Molecule Type:
Small molecule
Molecular Formula:
C22H23BrN6O2
Molecular Weight:
483.37
AlogP:
2.82
PSA:
136.1
HBD:
4.0
HBA:
#RotB:
4.0
Source:
RG7342
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Metabotropic glutamate receptor 5 modulator
RG7342
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ZIDEBACTAM
1
Small molecule
Investigational
Unknown
Unknown
Bacterial Infections
Unknown
ZIDEBACTAM
×
Maximum Phase:
1
First Approval:
None
UNII:
YPM97423DB
Molecule Type:
Small molecule
Molecular Formula:
C13H21N5O7S
Molecular Weight:
391.41
AlogP:
-1.86
PSA:
157.38
HBD:
4.0
HBA:
#RotB:
4.0
Source:
DPOC-4088
1
Small molecule
Investigational
Unknown
Unknown
Venous Thrombosis
Unknown
DPOC-4088
×
Maximum Phase:
1
First Approval:
None
UNII:
S6MPG81Y84
Molecule Type:
Small molecule
Molecular Formula:
C19H16ClF3N6O2
Molecular Weight:
452.82
AlogP:
2.35
PSA:
101.8
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TAS-115
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Hepatocyte growth factor receptor inhibitor
TAS-115
×
Maximum Phase:
1
First Approval:
None
UNII:
H2OL3Q4XRD
Molecule Type:
Small molecule
Molecular Formula:
C27H23FN4O4S
Molecular Weight:
518.57
AlogP:
4.59
PSA:
101.58
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TAS-116
1
Small molecule
Investigational
Unknown
Unknown
Gastrointestinal Stromal Tumors; Neoplasms
Unknown
TAS-116
×
Maximum Phase:
1
First Approval:
None
UNII:
PLO044MUDZ
Molecule Type:
Small molecule
Molecular Formula:
C25H26N8O
Molecular Weight:
454.54
AlogP:
3.79
PSA:
109.44
HBD:
1.0
HBA:
#RotB:
6.0
Source:
H-100
1
Small molecule
Investigational
Unknown
Unknown
Penile Induration
Unknown
H-100
×
Maximum Phase:
1
First Approval:
None
UNII:
5RQ73K2EC8
Molecule Type:
Small molecule
Molecular Formula:
C11H11N3O3
Molecular Weight:
233.23
AlogP:
0.44
PSA:
102.22
HBD:
3.0
HBA:
#RotB:
5.0
Source:
AZELOPRAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZELOPRAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
MIR2G6L61B
Molecule Type:
Small molecule
Molecular Formula:
C22H27N3O4S
Molecular Weight:
429.54
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CAFUSERTIB
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Neoplasms
Serine/threonine-protein kinase PLK1 inhibitor
CAFUSERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
UAB-30
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Intraductal, Noninfiltrating
Unknown
UAB-30
×
Maximum Phase:
1
First Approval:
None
UNII:
PFP09575EX
Molecule Type:
Small molecule
Molecular Formula:
C20H22O2
Molecular Weight:
294.39
AlogP:
4.94
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ILORASERTIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Platelet-derived growth factor receptor inhibitor
ILORASERTIB
×
Maximum Phase:
1
First Approval:
None
UNII:
6L5D03D975
Molecule Type:
Small molecule
Molecular Formula:
C25H21FN6O2S
Molecular Weight:
488.55
AlogP:
5.18
PSA:
118.09
HBD:
4.0
HBA:
#RotB:
6.0
Source:
RACLOPRIDE C 11
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Opioid-Related Disorders
Unknown
RACLOPRIDE C 11
×
Maximum Phase:
1
First Approval:
None
UNII:
GE077RPG04
Molecule Type:
Small molecule
Molecular Formula:
C15H20Cl2N2O3
Molecular Weight:
346.24
AlogP:
2.92
PSA:
61.8
HBD:
2.0
HBA:
#RotB:
5.0
Source:
HKI-357
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
HKI-357
×
Maximum Phase:
1
First Approval:
None
UNII:
39R3638KZ6
Molecule Type:
Small molecule
Molecular Formula:
C31H29ClFN5O3
Molecular Weight:
574.06
AlogP:
6.68
PSA:
99.51
HBD:
2.0
HBA:
#RotB:
11.0
Source:
PF-04995274
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant
Unknown
PF-04995274
×
Maximum Phase:
1
First Approval:
None
UNII:
XI179PG9LV
Molecule Type:
Small molecule
Molecular Formula:
C23H32N2O6
Molecular Weight:
432.52
AlogP:
2.63
PSA:
86.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
RESOLVIN E1
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RESOLVIN E1
×
Maximum Phase:
1
First Approval:
None
UNII:
GND3JH08JA
Molecule Type:
Small molecule
Molecular Formula:
C20H30O5
Molecular Weight:
350.46
AlogP:
2.91
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
13.0
Source:
TELENZEPINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TELENZEPINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0990EG3K10
Molecule Type:
Small molecule
Molecular Formula:
C19H22N4O2S
Molecular Weight:
370.48
AlogP:
2.53
PSA:
55.89
HBD:
1.0
HBA:
#RotB:
2.0
Source:
1
2
…
77
78
79
80
81
82
83
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA